País: Nova Zelândia
Língua: inglês
Origem: Medsafe (Medicines Safety Authority)
Adenosine 3 mg/mL (candida utilis lysed to get RNA,then hydrolysed to adenosine);
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Adenosine 3 mg/mL (candida utilis lysed to get RNA,then hydrolysed to adenosine)
6 mg/2mL
Solution for injection
Active: Adenosine 3 mg/mL (candida utilis lysed to get RNA,then hydrolysed to adenosine) Excipient: Sodium chloride Water for injection
Vial, glass, single dose, 6 x 2ml, 12 mL
Prescription
Prescription
Farmak a.s.
Adenocor is indicated for rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White syndrome), and as an aid to diagnosis of broad or narrow QRS complex supraventricular tachycardias, and in sensitisation of intracavity electrophysiological investigations.
Package - Contents - Shelf Life: Vial, glass, single dose, 6 x 2ml - 12 mL - 36 months from date of manufacture stored at or below 25°C
1993-09-22
Adenocor ® 1 ADENOCOR® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING ADENOCOR? Adenocor contains the active ingredient adenosine. Adenocor is used as an aid to doctors, to understand how your heart is working. Adenocor is a type of medicine used to treat a condition where the heart beats too rapidly. For more information, see Section 1. Why am I using Adenocor? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE ADENOCOR? Do not use if you have ever had an allergic reaction to Adenocor or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use Adenocor? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with Adenocor and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE ADENOCOR? • Adenocor will only be given to you in hospital. • Adenocor will be given to you as a rapid injection over a couple of seconds. More instructions can be found in Section 4. How do I use Adenocor? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING ADENOCOR? THINGS YOU SHOULD DO • Remind any doctor, dentist or pharmacist you visit that you have been given Adenocor. THINGS YOU SHOULD NOT DO • Do not eat or drink food or drinks containing caffeine (e.g. coffee, tea, chocolate or cola) for at least 12 hours before you receive your injection. LOOKING AFTER YOUR MEDICINE • Adenocor is stored in the pharmacy or on the ward. • Adenocor is kept in a cool, dry place where the temperature stays below 25°C. • Not to be refrigerated. For more information, see Section 5. What should I know while using Adenocor? in the full CMI. 6. ARE THERE ANY SIDE EFFECTS? T Leia o documento completo
New Zealand Data Sheet Adenocor - adenosine Property of the Sanofi group - strictly confidential adenocor-ccdsv9-dsv7-02sep22 Page 1 DATA SHEET 1 ADENOCOR 6 MG/2 ML SOLUTION FOR INTRAVENOUS INFUSION ADENOCOR 6 mg/2 mL solution for intravenous infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 6 mg of adenosine per 2 mL. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for intravenous infusion Clear, colourless solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS THERAPEUTIC INDICATIONS Rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White syndrome). DIAGNOSTIC INDICATIONS Aid to diagnosis of broad or narrow QRS complex supraventricular tachycardias. Although ADENOCOR is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of AV conduction helps diagnosis of atrial activity. Sensitisation of intracavity electrophysiological investigations. New Zealand Data Sheet Adenocor - adenosine Property of the Sanofi group - strictly confidential adenocor-ccdsv9-dsv7-02sep22 Page 2 4.2 DOSE AND METHOD OF ADMINISTRATION METHOD OF ADMINISTRATION ADENOCOR should be used only in hospitals, with monitoring and cardiorespiratory resuscitation equipment available for immediate use if necessary. It should be administered by rapid IV bolus injection according to the ascending dosage schedule below. To be certain the solution reaches the systemic circulation, it should be administered either directly into a vein or into an IV line. If administered via an IV line it should be injected as proximally as possible, and followed by a rapid saline flush. ADENOCOR should only be used when facilities exist for cardiac monitoring. Patients who develop high-level AV block at a particular dose should not be given further dosage increments. THERAPEUTIC DOSE _ADULTS _ Initial dose: 3 mg given as a rapid intravenous Leia o documento completo